title: HIV eradication: time to talk about a cure.
abstract: Since the earliest years of the epidemic, a cure has been the elusive "holy grail" of HIV/AIDS research. Several false starts and failed attempts gave rise to pessimism, and as efforts focused on improving antiretroviral therapy (ART) and managing its complications, the idea of HIV eradication faded into the background.
authors.affiliation: liz@hivandhepatitis.com
authors.forename: Liz
authors.initials: L
authors.lastname: Highleyman
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015316:Genetic Therapy; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D008213:Lymphocyte Activation; D019713:Receptors, CCR5 / Q000235:genetics; D019718:Receptors, CXCR4 / Q000276:immunology; D017735:Virus Latency
chemical_list: D019380:Anti-HIV Agents; C527276:CXCR4 protein, human; D056572:Histone Deacetylase Inhibitors; D019713:Receptors, CCR5; D019718:Receptors, CXCR4